Quest Partners LLC Sells 7,163 Shares of Doximity, Inc. (NASDAQ:DOCS)

Quest Partners LLC reduced its position in Doximity, Inc. (NASDAQ:DOCS) by 83.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,446 shares of the company’s stock after selling 7,163 shares during the period. Quest Partners LLC’s holdings in Doximity were worth $63,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Thrivent Financial for Lutherans raised its holdings in Doximity by 5.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock valued at $1,350,000 after acquiring an additional 1,474 shares during the period. Natixis Advisors LLC raised its stake in shares of Doximity by 43.5% during the 3rd quarter. Natixis Advisors LLC now owns 31,815 shares of the company’s stock valued at $1,386,000 after purchasing an additional 9,644 shares during the period. KBC Group NV lifted its holdings in Doximity by 22.9% during the 3rd quarter. KBC Group NV now owns 3,296 shares of the company’s stock worth $144,000 after purchasing an additional 614 shares in the last quarter. Oppenheimer & Co. Inc. boosted its stake in Doximity by 139.2% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 35,635 shares of the company’s stock worth $1,553,000 after purchasing an additional 20,740 shares during the period. Finally, Fountainhead AM LLC bought a new position in Doximity in the 3rd quarter worth about $710,000. 87.19% of the stock is currently owned by institutional investors.

Doximity Trading Down 0.7 %

DOCS stock opened at $53.00 on Friday. The firm’s 50-day moving average price is $45.86 and its two-hundred day moving average price is $36.09. The stock has a market capitalization of $9.89 billion, a price-to-earnings ratio of 60.92, a PEG ratio of 4.28 and a beta of 1.30. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DOCS. Evercore ISI increased their price target on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Bank of America raised their price target on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Barclays increased their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, November 11th. KeyCorp upgraded Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research note on Friday, November 8th. Finally, Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Eleven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity has an average rating of “Hold” and an average target price of $52.27.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.